<DOC>
	<DOCNO>NCT02342847</DOCNO>
	<brief_summary>This observational , post-authorization , prospective follow-up , multi-centre , national study design describe spectrum health-related quality life patient metastatic pancreatic cancer previously untreated chemotherapy This study design observe patient treated routine clinical practice , without exclusion limitation clinical trial . Patients enrol 7 Spanish site . In case , decision treat patient perform prior decision include patient study . Given observational nature study , follow-up patient perform accord standard clinical practice site .</brief_summary>
	<brief_title>Observational Study Quality Live Patients With Metastatic Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patients age ≥ 18 year . Patients diagnose metastatic pancreatic cancer confirm histologically cytologically Patients Karnofsky index ≥ 70 previously untreated chemotherapy . Patients life expectancy ≥ 6 month . Patients treat chemotherapy firstline treatment metastatic pancreatic cancer . * Informed consent write orally witness . The decision prescribe treatment clearly dissociate patient 's inclusion study . Therefore , choice therapeutic strategy make accord usual clinical practice independently doctor assess possible involvement patient study correspond inclusion Pregnant breastfeeding . Patients participate interventional clinical trial . Patients refuse participate study . Patients ability understand respond question related health .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>